|
End-of-day quote
Taiwan S.E.
2026-11-20
|
5-day change | 1st Jan Change | ||
| 1,100.00 TWD | -8.71% |
|
-20.29% | +159.62% |
| Nov. 19 | PharmaEssentia Seeks Brazil Approval for BESREMi in Essential Thrombocythemia | MT |
| Nov. 13 | PharmaEssentia Wins Mexico Approval for BESREMi to Treat Polycythemia Vera | MT |
| Market Cap | 456B 13.83B 12.6B 11.61B 10.56B 19.81B 1,281B 20.81B 141B 56.14B 699B 51.89B 50.79B 2,195B | P/E 2026 * |
42x | P/E 2027 * | 25.7x |
|---|---|---|---|---|---|
| Enterprise Value | 433B 13.13B 11.96B 11.02B 10.02B 18.8B 1,216B 19.76B 134B 53.3B 664B 49.26B 48.22B 2,084B | EV / Sales 2026 * |
15.3x | EV / Sales 2027 * | 9.78x |
| Free-Float |
79.22% | Yield 2026 * |
0.49% | Yield 2027 * | 0.21% |
| 1 day | -8.71% | ||
| 1 week | -20.29% | ||
| Current month | -7.56% | ||
| 1 month | -6.38% | ||
| 3 months | -21.43% | ||
| 6 months | +52.91% | ||
| Current year | +159.62% |
| 1 week | 1,085 | 1,385 | |
| 1 month | 1,075 | 1,410 | |
| Current year | 423.7 | 1,645 | |
| 1 year | 420.99 | 1,645 | |
| 3 years | 228.27 | 1,645 | |
| 5 years | 142.16 | 1,645 | |
| 10 years | 43.54 | 1,645 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 2016-12-31 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 2015-10-13 |
Cheng Ku Huang
PSD | President | - | 2015-06-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeffrey Williams
BRD | Director/Board Member | 73 | 2024-04-30 |
Shen Yi Li
BRD | Director/Board Member | - | 2021-08-04 |
Ching Tsun Liu
BRD | Director/Board Member | - | 2024-05-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.71% | -20.29% | +161.01% | +279.30% | 13.83B | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.55% | +89.34% | 58.56B | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 54.19B | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 44.66B | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 40.51B | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 36.27B | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 34.87B | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 32.26B | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 31.01B | ||
| Average | -2.11% | -2.60% | +45.86% | +190.42% | 41B | |
| Weighted average by Cap. | -1.72% | -2.30% | +36.19% | +159.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.21B 856M 779M 718M 653M 1.23B 79.24B 1.29B 8.74B 3.47B 43.28B 3.21B 3.14B 136B | 43.09B 1.31B 1.19B 1.1B 998M 1.87B 121B 1.97B 13.35B 5.31B 66.11B 4.9B 4.8B 207B |
| Net income | 10.92B 331M 302M 278M 253M 474M 30.66B 498M 3.38B 1.34B 16.75B 1.24B 1.22B 52.56B | 17.96B 545M 496M 457M 416M 780M 50.44B 820M 5.56B 2.21B 27.55B 2.04B 2B 86.46B |
| Net Debt | -23.05B -699M -637M -587M -534M -1B -64.74B -1.05B -7.14B -2.84B -35.36B -2.62B -2.57B -111B | -34.24B -1.04B -946M -872M -793M -1.49B -96.18B -1.56B -10.61B -4.22B -52.54B -3.9B -3.82B -165B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-20 | NT$1,100.00 | -8.71% | 5,224,260 |
| 26-11-19 | NT$1,205.00 | -3.21% | 3,604,921 |
| 26-11-18 | NT$1,245.00 | -2.73% | 2,788,165 |
| 26-11-17 | NT$1,280.00 | -1.16% | 3,852,848 |
| 26-11-16 | NT$1,295.00 | -6.16% | 3,729,664 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
















